Search results
Found 864 matches for
On Replay
The theme for the conference this year is 'Reimagining Dementia Research'. It's an opportunity to hear about new developments in dementia research and to join discussions about biomarkers, data and delivering trials – all of which can lead to new disease-modifying treatments for dementia.
Speakers
Introducing our speakers
Vascular health and dementia
DPUK's Experimental Medicine Incubator supports clinical research that aims to reduce the time, cost and risk of drug development. Dr Atticus Hainsworth, who leads the Vascular Health Theme of DPUK's Experimental Medicine Incubator, discusses the links between the vascular system and dementia - and how DPUK's vascular research group is enhancing our ability to bring forward new treatments.
One man's experience of mixed dementia
The goal of dementia research is to improve the lives of people with the condition and ultimately create a world free from dementia. Hear from John – a 93-year-old living with Alzheimer's disease and vascular dementia – discussing his experiences of mixed dementia with his grandaughter.
Volunteer stories: Bernard Clarke
Bernard Clarke (77), from Oxford, was the first volunteer to sign up to the Deep and Frequent Phenotyping (DFP) study – the most detailed study of its kind into early Alzheimer's disease.
Featured cohort: Generation Scotland
Cohorts are groups of people with a shared characteristic – Generation Scotland is a cohort available in the DPUK Data Portal. The DPUK Data Portal contains around 50 cohorts of volunteers whose data is collected over several years. Researchers study the cohorts in the DPUK Data Portal to identify the earliest signs of dementia. Learn more about the Generation Scotland cohort in this video.
The future of dementia research
A short podcast interview with DPUK Director Professor John Gallacher exploring what the future of dementia research holds. Professor Gallacher reveals that if we can delay the onset of dementia by just five years, we can reduce the number of people who have dementia by 35%.